1. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015, CA. Cancer J Clin. 2016; 66: 115-132.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics, CA. Cancer J Clin. 2011; 61: 69-90.
3. Naidich DP, Bankier AA, MacMahon H, Schaefer-Prokop CM, Pistolesi M, Goo JM, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology. 2013; 266: 304-317.
4. Qiu ZX, Cheng Y, Liu D, Wang WY, Wu X, Wu WL, et al. Clinical, pathological, and radiological characteristics of solitary ground-glass opacity lung nodules on high-resolution computed tomography. Ther Clin Risk Manag. 2016; 12: 1445-1453.
5. Chung K, Jacobs C, Scholten ET, Goo JM, Prosch H, Sverzellati N et al. Lung-RADS category 4X: does it improve prediction of malignancy in subsolid nodules? Radiology. 2017; 284: 264–271.
6. Hu H, Wang Q, Tang H, Xiong L, Lin Q. Multi-slice computed tomography characteristics of solitary pulmonary ground-glass nodules: Differences between malignant and benign. Thorac Cancer. 2016; 7: 80-87.
7. Lee HY, Choi YL, Lee KS, Han J, Zo JI, Shim YM. et al. Pure ground-glass opacity neoplastic lung nodules: histopathology, imaging, and management. AJR. Am J Roentgenol. 2014; 202: 224-33.
8. Wu F, Tian SP, Jin X, Jing R, Yang YQ, Jin M et al. CT and histopathologic characteristics of lung adenocarcinoma with pure ground-glass nodules 10 mm or less in diameter. Eur Radiol. 2017; 27: 1-7.
9. Walter JE, Heuvelmans MA, Bock GH, Yousaf-Khan U, Groen HJM, Aalst CMV. et al. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study. Thorax. 2018; 73: 741-747.
10. Walter JE, Heuvelmans MA, de Jong PA, Vliegenthart R, van Ooijen PMA, Peters RB, et al. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Lancet Oncol. 2016; 17: 907-916.
11. Shinohara S, Hanagiri T, Takenaka M, Chikaishi Y, Oka S, Shimokawa, H, et al. Evaluation of undiagnosed solitary lung nodules according to the probability of malignancy in the American College of Chest Physicians (ACCP) evidence-based clinical practice guidelines. Radiol Oncol. 2014; 48: 50-55.
12. Sim YT, Poon FW. Imaging of solitary pulmonary nodule-a clinical review. Quant Imaging Med Surg. 2013; 3: 316-326.
13. Henschke CI, Yankelevitz DF, Reeves AP, Cham MD. Image analysis of small pulmonary nodules identified by computed tomography. Mt Sinai J Med. 2011; 78: 882-93.
14. Oda S, Awai K, Murao K, Ozawa A, Utsunomiya D, Yanaga Y, et al. Volume-doubling time of pulmonary nodules with ground glass opacity at multidetector CT: Assessment with computer aided three-dimensional volumetry. Acad Radiol. 2011; 18: 63-69.
15. Wang X, Han R, Guo F, Li X, Zheng W, Wang Q, et al. Analysis of Growth Curve Type in Pulmonary Nodules with Different Characteristics, Zhongguo Fei Ai Za Zhi. 2017; 20: 334-340.
16. Hasegawa M, Sone S, Takashima S, Li F, Yang ZG, Maruyama Y, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol. 2000; 73: 1252-1259.
17. Zhong W, Yang X, Bai J, Yang J, Manegold C, Wu Y. Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer. Eur J Cardiothorac Surg. 2008; 34: 187-195.
18. Wolf AS, Richards WG, Jaklitsch MT, Gill R, Chirieac LR, Colson YL, et al. Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers. Ann Thorac Surg. 2011; 92: 1819-1823.
19. Lee SM, Park CM, Paeng JC, Im HJ, Goo JM, Lee HJ, et al. Accuracy and predictive features of FDG-PET/CT and CT for diagnosis of lymph node metastasis of T1 non-small-cell lung cancer manifesting as a subsolid nodule. Eur Radiol. 2012; 22: 1556-1563.
20. Snoeckx A, Reyntiens P, Desbuquoit D, Spinhoven MJ, Van Schil PE, van Meerbeeck JP, et al. Evaluation of the solitary pulmonary nodule: size matters, but do not ignore the power of morphology. Insights Imaging. 2018; 9: 73-86.
21. Ost DE, Gould MK. Decision Making in Patients with Pulmonary Nodules. Am J Respir Crit Care Med. 2012; 185: 363-372.
22. Wang X, Lv L, Zheng Q, Huang X, Li B. Differential diagnostic value of 64 slice spiral computed tomographvy in solitary pulmonary nodule. Exp Ther Med. 2018; 15: 4703-4708.
23. Harders SW, Madsen HH, Rasmussen TR, Hager H, Rasmussen F. High resolution spiral CT for determining the malignant potential of solitary pulmonary nodules: refining and testing the test. Acta Radiol. 2011; 52: 401-409.
24. Miyamoto A, Kurosaki A, Fujii T, Kishi K, Homma S. HRCT features of surgically resected invasive mucinous adenocarcinoma associated with interstitial pneumonia. Respirology. 2017; 22: 735-743.
25. Oda S, Awai K, Liu D, Nakaura T, Yanaga Y, Nomori H, et al. Ground-Glass Opacities on Thin-Section Helical CT: Differentiation Between Bronchioloalveolar Carcinoma and Atypical Adenomatous Hyperplasia. AJR. Am J Roentgenol. 2012; 190: 1363-1368.
26. Gould MK, Donington J, Lynch WR, Mazzone PJ, Midthun DE, Naidich DP, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143: e93S-120S.
27. Patel VK, Naik SK, Naidich DP, Travis WD, Weingarten JA, Lazzaro R, et al. A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 1: radiologic characteristics and imaging modalities. Chest. 2013; 143: 825-39.
28. Pinsky PF, Gierada DS, Nath PH, Munden R. Lung cancer risk associated with new solid nodules in the national lung screening trial. AJR. Am J Roentgenol. 2017; 209: 1-6.
29. Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Tazelaar HD, et al. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology. 2007; 242: 555-562.
30. Swensen SJ, Silverstein MD, Ilstrup DM, Schleck CD, Edell ES. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med. 1997; 157: 849-855.
31. Perandini S, Soardi G, Motton M, Oliboni E, Zantedeschi L, Montemezzi S. Distribution of Solid Solitary Pulmonary Nodules within the Lungs on Computed Tomography: A Review of 208 Consecutive Lesions of Biopsy-Proven Nature. Pol J Radiol. 2016; 81, 146-151.
32. Ohno Y, Hatabu H, Takenaka D, Higashino T, Watanabe H, Ohbayashi C, et al. CT-guided transthoracic needle aspiration biopsy of small (< or = 20 mm) solitary pulmonary nodules. AJR. Am J Roentgenol. 2003; 180: 1665-9.
33. Siegelman SS, Khouri NF, Leo FP, Fishman EK, Braverman RM, Zerhouni EA. Solitary pulmonary nodules: CT assessment. Radiology. 1986; 160: 307-312.
34. Grewal, RG, Austin, JH. CT demonstration of calcification in carcinoma of the lung, J Comput Assist Tomogr. 1994; 18: 867-871.
35. Zwirewich CV, Vedal S, Miller RR, Müller NL. Solitary pulmonary nodule: high-resolution CT radiologic-pathologic correlation. Radiology. 1991; 179: 469-76.
36. Chu ZG, Sheng B, Liu MQ, Lv FJ, Li Q, Ouyang Y. Differential Diagnosis of Solitary Pulmonary Inflammatory Lesions and Peripheral Lung Cancers with Contrast-enhanced Computed Tomography. Clinics. (Sao Paulo). 2016; 71: 555-561.
37. Nambu A, Araki T, Taguchi Y, Ozawa K, Miyata K, Miyazawa, M, et al. Focal area of ground-glass opacity and ground-glass opacity predominance on thin-section CT: discrimination between neoplastic and non-neoplastic lesions. Clin Radiol. 2005; 60: 1006-1017.